Log in to save to my catalogue

Vimentin is a novel AKT1 target mediating motility and invasion

Vimentin is a novel AKT1 target mediating motility and invasion

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3010301

Vimentin is a novel AKT1 target mediating motility and invasion

About this item

Full title

Vimentin is a novel AKT1 target mediating motility and invasion

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2011-01, Vol.30 (4), p.457-470

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The PI3K/AKT signaling pathway is aberrant in a wide variety of cancers. Downstream effectors of AKT are involved in survival, growth and metabolic-related pathways. In contrast, contradictory data relating to AKT effects on cell motility and invasion, crucial prometastatic processes, have been reported pointing to a potential cell type and isoform...

Alternative Titles

Full title

Vimentin is a novel AKT1 target mediating motility and invasion

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3010301

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3010301

Other Identifiers

ISSN

0950-9232

E-ISSN

1476-5594

DOI

10.1038/onc.2010.421

How to access this item